| Profile for maltuepoimelongbram |
|---|
|
Signature400 mg PO/IV qDay for 5-10 days. Limitations-of-use: Reserve fluoroquinolones for patients who do not have other available treatment options for acuteDosing Considerations. Initial IV administration may be changed to PO administration at same dosage to complete therapy, depending on patient's... |
